
MOTS-c (Mitochondrial Open Reading Frame–C) is a synthetic research peptide modeled after a naturally occurring 16-amino-acid mitochondria-derived sequence, used strictly as a research chemical and studied for its potential roles in metabolic regulation, AMPK activation, and cellular stress responses; it is not an approved drug, and its safety, efficacy, and appropriate dosing in humans have not been clinically validated.